Arsenal Capital Partners

News

Cello Health has been acquired by Arsenal Capital Partners, a private equity firm investing in healthcare and industrials companies.

News

Amgen's Lumykras will no longer be funded by the Cancer Drugs Fund for KRAS-mutated lung cancer, says NHS reimbursement authority NICE.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.